Radiology, Vol 184, 687-694, Copyright © 1992 by Radiological Society of North America

ARTICLES

Focal liver disease: comparison of dynamic contrast-enhanced CT and T2- weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T

RC Semelka, JP Shoenut, MA Kroeker, HM Greenberg, FC Simm, GY Minuk, RM Kroeker and AB Micflikier
Department of Radiology, St Boniface General Hospital MRI Facility, Winnipeg, Man., Canada.

Dynamic contrast medium-enhanced computed tomography (CT), T2-weighted fat-suppressed spin-echo (T2FS) magnetic resonance (MR) imaging, and breath-hold T1-weighted fast low-angle shot (FLASH) MR imaging before and after dynamic gadopentetate dimeglumine injection were compared in 73 patients with clinically suspected liver disease. Observer confidence for presence of focal lesions was determined by using receiver operating characteristic analysis. For all MR images, hepatic lesion-liver signal-to-noise ratios were evaluated qualitatively. and resolution and presence of artifacts were evaluated qualitatively. Lesion detection was greatest with T2FS (n = 272) and enhanced FLASH (n = 244) and was statistically greater with both of these than with CT (n = 220) and FLASH (n = 219) (P less than .03). Correct lesion characterization was greatest with enhanced FLASH (n = 236) (P less than .01), followed by CT (n = 199), FLASH (n = 164), and T2FS (n = 144). Enhanced FLASH was particularly successful in characterization of 5-mm- to 1.5-cm-diameter lesions as cystic or solid.

This article has been cited by other articles:

				T. Parikh, S. J. Drew, V. S. Lee, S. Wong, E. M. Hecht, J. S. Babb, and B. Taouli Focal Liver Lesion Detection and Characterization with Diffusion-weighted MR Imaging: Comparison with Standard Breath-hold T2-weighted Imaging Radiology, March 1, 2008; 246(3): 812 - 822. [Abstract] [Full Text] [PDF]

				Y. K. Kim, K. Y. Jang, B. H. Cho, S. W. Ko, and W. S. Moon Three-Phase Dynamic CT of Pelioid Hepatocellular Carcinoma Am. J. Roentgenol., September 1, 2007; 189(3): W160 - W162. [Full Text] [PDF]

				E. M. Hecht, A. E. Holland, G. M. Israel, W. Y. Hahn, D. C. Kim, A. B. West, J. S. Babb, B. Taouli, V. S. Lee, and G. A. Krinsky Hepatocellular Carcinoma in the Cirrhotic Liver: Gadolinium-enhanced 3D T1-weighted MR Imaging as a Stand-alone Sequence for Diagnosis. Radiology, May 1, 2006; 239(2): 438 - 447. [Abstract] [Full Text] [PDF]

				J. H. Youk, J. M. Lee, and C. S. Kim MRI for Detection of Hepatocellular Carcinoma: Comparison of Mangafodipir Trisodium and Gadopentetate Dimeglumine Contrast Agents Am. J. Roentgenol., October 1, 2004; 183(4): 1049 - 1054. [Abstract] [Full Text] [PDF]

				J. F. Schaefer, J. Vollmar, F. Schick, R. Vonthein, M. D. Seemann, H. Aebert, R. Dierkesmann, G. Friedel, and C. D. Claussen Solitary Pulmonary Nodules: Dynamic Contrast-enhanced MR Imaging--Perfusion Differences in Malignant and Benign Lesions Radiology, August 1, 2004; 232(2): 544 - 553. [Abstract] [Full Text] [PDF]

				Y. K. Kim, C. S. Kim, Y. H. Lee, H. S. Kwak, and J. M. Lee Comparison of Superparamagnetic Iron Oxide-Enhanced and Gadobenate Dimeglumine-Enhanced Dynamic MRI for Detection of Small Hepatocellular Carcinomas Am. J. Roentgenol., May 1, 2004; 182(5): 1217 - 1223. [Abstract] [Full Text] [PDF]

				H. K. Hussain, I. Syed, H. V. Nghiem, T. D. Johnson, R. C. Carlos, W. J. Weadock, and I. R. Francis T2-weighted MR Imaging in the Assessment of Cirrhotic Liver Radiology, March 1, 2004; 230(3): 637 - 644. [Abstract] [Full Text] [PDF]

				R. C. Carlos, H. M. Kim, H. K. Hussain, I. R. Francis, H. V. Nghiem, and A. M. Fendrick Developing a Prediction Rule to Assess Hepatic Malignancy in Patients with Cirrhosis Am. J. Roentgenol., April 1, 2003; 180(4): 893 - 900. [Abstract] [Full Text] [PDF]

				G. C. Mueller, H. K. Hussain, R. C. Carlos, H. V. Nghiem, and I. R. Francis Effectiveness of MR Imaging in Characterizing Small Hepatic Lesions: Routine Versus Expert Interpretation Am. J. Roentgenol., March 1, 2003; 180(3): 673 - 680. [Abstract] [Full Text] [PDF]

				A. Ba-Ssalamah, W. Schima, M. T. Schmook, K. F. Linnau, N. Schibany, T. Helbich, P. Reimer, F. Laengle, F. Wrba, A. Kurtaran, et al. Atypical Focal Nodular Hyperplasia of the Liver: Imaging Features of Nonspecific and Liver-Specific MR Contrast Agents Am. J. Roentgenol., December 1, 2002; 179(6): 1447 - 1456. [Abstract] [Full Text] [PDF]

				L. Grazioli, M. P. Federle, G. Brancatelli, T. Ichikawa, L. Olivetti, and A. Blachar Hepatic Adenomas: Imaging and Pathologic Findings RadioGraphics, July 1, 2001; 21(4): 877 - 892. [Abstract] [Full Text] [PDF]

				R. C. Semelka and T. K. G. Helmberger Contrast Agents for MR Imaging of the Liver Radiology, January 1, 2001; 218(1): 27 - 38. [Abstract] [Full Text]

				G. Pirovano, A. Vanzulli, L. Marti-Bonmati, L. Grazioli, R. Manfredi, A. Greco, N. Holzknecht, H. E. Daldrup-Link, E. Rummeny, B. Hamm, et al. Evaluation of the Accuracy of Gadobenate Dimeglumine-Enhanced MR Imaging in the Detection and Characterization of Focal Liver Lesions Am. J. Roentgenol., October 1, 2000; 175(4): 1111 - 1120. [Abstract] [Full Text] [PDF]

				M.-G. Jeong, J.-S. Yu, and K. W. Kim Hepatic Cavernous Hemangioma: Temporal Peritumoral Enhancement during Multiphase Dynamic MR Imaging Radiology, September 1, 2000; 216(3): 692 - 697. [Abstract] [Full Text]

				G. T. Sica, H. Ji, and P. R. Ros CT and MR Imaging of Hepatic Metastases Am. J. Roentgenol., March 1, 2000; 174(3): 691 - 698. [Full Text] [PDF]

				G. L. Bennett, A. Petersein, W. W. Mayo-Smith, P. F. Hahn, W. Schima, and S. Saini Addition of Gadolinium Chelates to Heavily T2-Weighted MR Imaging: Limited Role in Differentiating Hepatic Hemangiomas from Metastases Am. J. Roentgenol., February 1, 2000; 174(2): 477 - 485. [Abstract] [Full Text] [PDF]

				D. Pauleit, J. Textor, R. Bachmann, R. Conrad, S. Flacke, G. Layer, B. Kreft, and H. Schild Hepatocellular Carcinoma: Detection with Gadolinium- and Ferumoxides-enhanced MR Imaging of the Liver Radiology, January 1, 2002; 222(1): 73 - 80. [Abstract] [Full Text] [PDF]